| CPC A61K 36/484 (2013.01) [A23L 33/105 (2016.08); A23L 33/40 (2016.08); A61K 9/0056 (2013.01); A61K 31/12 (2013.01); A61K 31/353 (2013.01); A61P 21/00 (2018.01); A23V 2002/00 (2013.01); A61K 2236/331 (2013.01); A61K 2236/333 (2013.01)] | 7 Claims |
|
1. A method of preventing or treating muscle diseases in a subject, comprising:
providing a pharmaceutical composition comprising licorice extract containing a compound represented by the following formula 3, as an active ingredient,
![]() and
administering the pharmaceutical composition to the subject, wherein the muscle diseases are prevented or treated, wherein the muscle diseases are selected from the group consisting of muscular dystrophy, sarcopenia, myopathy, and myasthenia,
wherein the compound is obtained by extracting licorice with distilled water at 110 to 120° C. for 2 to 4 hours and fractioning the licorice extract with dichloromethane ethyl acetate or N-butanol.
|